Contribution of [18F]DPA-714 PET for grading and exploration of the inflammatory microenvironment of glioma, a pilot study.
- Conditions
- glioma (grade OMS II à IV)MedDRA version: 20.0Level: PTClassification code 10018338Term: GliomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- EUCTR2022-002599-35-FR
- Lead Sponsor
- Centre de Lutte Contre le Cancer Eugène Marquis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 20
1.Age greater than or equal to 18 years
2.Suspicion of an operable diffuse glioma
3.Written informed consent (signed)
4.Affiliated or beneficiary of a social security plan
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 10
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 10
1.Suspicion de gliome de grade I
2.Urgence chirurgicale (délai inférieur à 8 jours entre la suspicion diagnostique et la chirurgie)
3.Femme enceinte ou en cours d'allaitement
4.Personnes privées de liberté ou sous tutelle
5.Impossibilité de se soumettre au suivi médical de l'essai pour des raisons géographiques, sociales ou psychiques
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method